UNPRF yields 1.97% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, UNPRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UNPRF + PFE for your $10,000?
Uniper SE operates as an energy company. It operates in three segments: European Generation, Global Commodities, and Russian Power Generation. The company owns and operates various power and heat generation facilities, including fossil fuel power plants, such as coal, gas, oil, and combined gas and steam; and hydroelectric, nuclear, biomass, photovoltaic, and wind power plants. It also markets energy services comprising fuel procurement, and engineering and asset management, as well as operational and maintenance services; and procures fuels, trades in emission allowances, and markets electricity. In addition, the company engages in the sale of individual power and natural gas to resellers, industrial customers, and power plant operators; energy trading activities; infrastructure investments and gas storage operations; fuel procurement for power plants; operation and management of the plants; and trade and sale of energy. Further, it trades in commodities, which comprise power, natural gas, liquefied natural gas, and coal and freight solutions; provides district heating and online gas dispatch services; operates gas storage and power-to-gas facilities in Germany, Austria, and the United Kingdom; and owns and operates marine fuel oils production facility in Fujairah. It operates in Germany, the United Kingdom, the Russian Federation, rest of Europe, and internationally. The company was founded in 2016 and is headquartered in Düsseldorf, Germany. Uniper SE is a subsidiary of Karemi Charge and Drive SE.
Full UNPRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.